InvestorsHub Logo
Followers 6
Posts 438
Boards Moderated 0
Alias Born 09/05/2019

Re: None

Tuesday, 08/18/2020 10:36:26 AM

Tuesday, August 18, 2020 10:36:26 AM

Post# of 26552
Nice to see signs of new business development here, goes hand in hand with the accumulation a lot of us have noticed over the last few months. I would say there is much more to unfold here in the next little while.

Hoping to start getting some DD together on the new President, as well as what the new potential MS patent may be. I am speculating a new CEO, and potentially some sort of funding + investigative contracts may be announced at some point, as this is something the company has been trying to sort out for years now. The business plan has had a lot of potential in my opinion. Many have abandoned hope, but I think it has just taken a lot longer to get out of the woods than some expected.

"Mr. Katzaroff is in discussions with the holder of a patented treatment for Multiple Sclerosis with the intent to negotiate an exclusive perpetual license." Interesting to note here as well how closely linked Multiple Sclerosis and type 1 diabetes are, in terms of the demographic that they affect. I wonder if they are going to reignite their efforts to get Liprsostin into Phase 3 trials in contingent with the MS patent that was mentioned. Or, perhaps they truly have abandoned Liprostin and are trying to leverage the work they have done and pivot to this new business direction. Time will tell. Chart is set, bring on the PRs and volume. Good luck to all.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GSTC News